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Abstract
Objective This prospective controlled study evaluated the effect of bone-anchored maxillary protraction therapy in cleft children
with Class III malocclusion using CBCT-derived 3D surface models.
Materials and subjects Eighteen cleft patients between 10 and 12 years old were included. Intermaxillary elastics were worn after
the placement of four zygoma bone plates for 18 months. Uniquely, three age-matched untreated groups including both cleft
subjects and non-cleft subjects with Class III malocclusion served as controls. Profile photos and CBCT scans for each patient
were taken before (T0) and 18months after the protraction (T1). 3Dmeasurements were made on CBCTsurface models from the
treatment group using tomographic color mapping method. Cephalometric measurements were made on lateral cephalogram
reconstructed from the CBCT scans and were compared with those obtained from the control groups.
Results Two thirds of the treatment subjects showed improved lip projection towards more convex facial profile. The most
significant skeletal changes on 3D surface models were observed at the zygomatic regions (mean 1.5-mm forward, downward,
and outward displacement) and at the maxillary complex (mean 1.5-mm forward displacement). Compared with the control
groups, the treatment subjects showed significant increase in the SNA and ANB angles, increasedWits appraisal, a more forward
movement of point A and overjet improvement (p < 0.05).
Conclusions BAMP in cleft patients gives a significant forward displacement of the zygomaxillairy complex in favor of the Class
III treatment.
Clinical relevance This treatment method shows clearly favorable outcome in cleft patients after 1.5 years of BAMP.
Keywords CBCT .Boneanchored .Maxillofacial protraction .Colormapping .Superimposition .Cleft .Orthodontics .Class III
malocclusion
Introduction
Class III malocclusion is a common anomaly in children with
cleft lip and or palate mainly due to maxillary deficiency.
Conventionally, growing subjects with maxillary deficiency
were treated with a facemask (FM) with a heavy anterior
traction applied on the maxilla to stimulate its forward and
downward movement and to restrain and redirect mandibular
growth. There is some evidence showing more favorable re-
sults with facemask therapy on early age [1, 2]. However, the
best treatment timing and duration for facemask therapy re-
mains controversial, and the skeletal and dental changes were
adequately tested only in the short term. Long-term results and
stability of this treatment modality remain debatable [3, 4].
Moreover, undesirable treatment outcomes of face mask have
been reported such as dental compensations as a consequence
of the application of forces on the teeth and an increased facial
vertical dimension as a result of posterior rotation of the man-
dible. Additionally, facemask wear heavily relies on patient
compliance and is usually limited to 12–14 h/day due to the
social barrier [1, 5, 6]. The addition of rapid maxillary expan-
sion (RME) showed enhanced effect of the FM therapy. Less
dental compensations are demonstrated when a facemask used
in combination with a Hybrid Hyrax, a rapid palatal expansion
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appliance which is both tooth- and bone-borne. [7]. Protocols
of maxillary expansion and protraction, such as the Alternate
Rapid maxillary Expansions and Constrictions protocol(Alt-
RAMEC), proposed by Liou et al., showed favorable skeletal
results up to 17 to 21 years of age in some patient, but with
evident dental compensation [8, 9].
In recent years, titanium miniplates used for anchorage has
been advocated as an alternative treatment modality to apply
bone-borne orthopedic forces between the maxilla and the
mandible, therewith minimizing dentoalveolar compensations
[10, 11]. Compared with treatment with facemask in combi-
nation with rapid maxillary expansion, bone-anchored maxil-
lary protraction produced 2- to 3-mm larger maxillary ad-
vancement with similar mandibular sagittal changes, better
vertical control, and a lack of posterior rotation of the mandi-
ble demonstrated by both 3D CBCT images and 2D
cephalograms [12, 13]. Compared with untreated non-cleft
subjects with Class III malocclusions, bone-anchored pro-
traction induced an average increment of 4 mm on maxil-
lary advancement and favorable mandibular changes ex-
ceeding 2 mm based on cephalometric analyses [14].
Though anchored maxillary protraction has showed favor-
able results in non-cleft growing subjects, no previous
study has investigated the effect of this treatment modality
on maxillofacial complex in cleft patients until very recent-
ly [15]. In that study, Yatabe et al. (2017) compared a
group of Brazilian cleft patients with a group of Belgian
non-cleft subjects on CBCT models and reported compa-
rable efficacy in maxillary displacement in the two groups.
Till date, no studies have compared the outcome of bone-
anchored protraction therapy in cleft patients with that in
untreated Class III non-cleft patients or Class I or II cleft
subjects, nor have any studies investigated the lip projec-
tion changes on facial profiles.
Growth trends are intrinsically different in different fa-
cial types and skeletal anomalies [16]. Facial growth in
cleft children showed different patterns from non-cleft
subjects with similar malocclusions [17]. In the develop-
ment of Class III malocclusion, non-cleft and cleft sub-
jects bear different etiologies [18, 19]. These observations
point out the importance of including both non-cleft and
cleft subjects as controls in order to illustrate the treatment
outcome of a specific intervention. Comparisons only with
non-cleft subjects undergoing the same therapy or with
untreated non-cleft subjects may obscure the actual cranio-
facial response of cleft subjects to an intended therapy.
Therefore, the aim of this prospective controlled trial
(National Trial Registration TC 6559) is to evaluate the treat-
ment efficacy of bone-anchored maxillary protraction in
growing unilateral complete cleft lip and palate patients with
Class III malocclusion on 3D surface models derived from a
Cone Beam CT, and on 2D cephalograms in comparison with
three cleft and non-cleft control groups.
Subjects and methods
This clinical study is conducted in agreement with the rules
established by the Ethics Committee at the UniversityMedical
Centre Groningen (Clinical Study Register no.: 201700423,
Ethical approval no.: METc 2017/318, The Netherlands
National Trial Registration TC 6559).
Study subjects
All patients with unilateral complete cleft lip and palate be-
tween 10 and 12 years were included. The last included pa-
tient started maxillary protraction in June 2015, when the
minimally required sample size was reached based on a power
analysis. This group is named as Treatment Group - Cleft
(TG-C). All patients have been under treatment by one ortho-
dontist at Department of Orthodontics of University Medical
Center Groningen, the Netherlands, and have undergone a
series of interdisciplinary treatments within the same medical
center. The clinical decision for treatment with maxillary pro-
traction was primarily based on the skeletal relationship. The
inclusion criteria were (1.) All patients had previously a sec-
ondary bone transplantation procedure by the same surgeon;
(2.) Both lower permanent canines have erupted; (3.) Sagittal
overjet was between + 2 mm and − 5 mm or with an ANB
angle < 0°or a WITs < 0 mm; (4.) Prior to bone-anchored
protraction, the patients had undergone no or only mild dental
alignment in the upper jaw in preparation for bone
transplantation.
Three untreated control groups with two cephalograms
available were matched with the treatment group by age. A
non-cleft group with Class III malocclusion (UG-nonC,
ANB < 0° or WITs < 0 mm) was collected from the
Groningen Longitudinal Elementary Growth Study [20].
A cohort of untreated subjects with cleft, collected from
the university clinical archives, was assigned to either a
Class III malocclusion group (UG-C1 when ANB < 0° or
WITs < 0 mm) or a Class I or II malocclusion group (UG-
C2 when ANB ≥ 0° or WITs ≥ 0 mm). These cleft subjects
had undergone no or only mild dental alignment in the
upper jaw during the observation period.
Bone-anchored maxillary protraction
Four Bollard bone plates were placed by the same surgeon at
the age of 11 years under general anesthesia according to
previous studies [21]. Maxillary protraction with
intermaxillary elastics was started 3 weeks after the placement
with an initial force of 150 g each side which was increased to
200–250 g after 2–3 months. All patients were instructed to
wear the elastics 24 h per day including meal time and change
the elastics once a day.
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CBCT imaging acquisition
The Cone Beam Computed Tomography (CBCT) scans were
performed using the KaVo 3D eXam CBCT unit (KaVo
Dental GmbH, Bismarckring, Germany) for scans before
April 2016, and the Planmeca ProMax 3D Mid (Planmeca
Oy, Helsinki, Finland) for scans after April 2016. The former
used a 170 × 230-mm field of view (FoV), set at 120 kV and
42.5 mAs with an isotropic voxel size of 0.3 mm. The
Planmeca ProMax 3D was set at 90 kVand 20.25 mAs using
a 170 × 200-mm field of view with an isotopic voxel size of
0.3 mm. The patients were placed in the scanner with the
Frankfurt Horizontal (FH) plane parallel to the ground and
centrally positioned in the FoV with the aid of the laser align-
ment lights of the unit. The presence of a functional shift is
examined prior to the acquisition of the CBCT scan by the
orthodontist (YR). No functional shift appeared present in the
treatment group. All scans were made at the centric occlusion.
The CBCT scans were performed before the start of maxillary
protraction (T0) and approximately 18 months after (T1),
BAMP continued after T1. The scan data were exported to
DICOM format and imported to specialized software
(Mimics10.01 Materialize, V10.2.1.2) for segmentation of
the hard tissues. The segmentation technique was based on
pixel intensity differentiation thresholding and active contour
tracing. Following this technique, the segmented hard tissue
data are finally exported as a polygon 3D surface model in the
industry standard STL format. Additionally, out of the CBCT
scans of each patient, a 2D lateral cephalogram was recon-
structed according to previous studies [22, 23] at T0 and T1
for the cephalometric comparisons with the control groups.
Facial profile photos and lip projection analysis
A standardized facial profile photo was taken for each
patient at T0 and T1 during the same session when the
CBCT scan was made, all by the same specialized techni-
cian (AD). Patients were seated and were asked to look
into the mirror in front when the photo was taken. The
most outer points of the upper and lower vermilion were
identified putting the photo on a full screen size and a lip
line was then drawn between the two points. Lip projec-
tion was measured as the upper angle between the lip line
and the true vertical line, with inward angles denoted as
negative (concave) and outward angles denoted as positive
(convex).
Superimposition of the CBCT 3D surface models
The 3D models were imported in Geomagic (version
2013.0.1.1206, Geomagic Solutions®, USA) for a three-
dimensional comparison between T0 and T1 for each patient.
The anterior cranial fossa and the occipital area posterior of
the foramen magnum were selected as stable structures for
superimposition. Automatic best-fit matching was performed
on the selected areas for cranial base superimposition of the
T1model over the T0 (reference) model. Besides visualization
of the surface discrepancies by means of color mapping, skel-
etal differences were also quantified at selected regions of
interest (ROIs) surrounding the Nasion (N), the right and left
zygomatic processes (Zyg), the A point (A), the B point (B),
and the Pogonion (Pg). The ROIs had an area of 4.5 mm2
around every anatomic point, containing approximately 70
polygons each according to previous studies [18]. The use of
ROIs instead of single points was chosen in order to avoid
false measurements due to a potentially outlying single poly-
gon caused by, e.g., an artifact. Instead, the mean difference in
millimeter of all individual polygons within the selected ROIs
was measured, which translate into the total displacement of
the ROIs. Furthermore, by using the FH plane as the reference
plane, the horizontal, vertical, or transversal component of
each ROI displacement could be calculated (Fig. 1).
Cephalometric measurements and superimposition
The lateral cephalograms of all four groups at T0 and T1 were
scaled to the same magnification and were traced and
superimposed on the anterior cranial base using the Viewbox
software (version 10.1 dHal, Kifissia, Greece). The total dis-
placement of the Nasion, A, B, and Pg was measured and
analyzed to their vertical and horizontal components.
Statistics
Prior to the research, a power analysis was performed with
an effect size of ρ = 0.5 with a power of 0.8, resulting in a
total sample size of 21 patients. The same observer (RS)
did all lip projection measurements randomly three times
with an interval of at least 1 week. Intraclass correlation on
these measurements was calculated. 3D cephalomeric
landmarks and their surrounding ROIs were defined and
the differences were measured by the same experienced
examiner (RS), who performed also all cephalometric trac-
ings and superimposition with both 3D surface models and
2D cephalograms assigned randomly. For the intraclass
correlation, 3D ROI measurements and superimposion,
and 2D cephalometrics were performed twice with 1-
week interval. The statistical analyses were performed with
SPSS (version 23.0; IBM U.S.A.). For cephalometric anal-
ysis, a one way ANOVA test was performed with a post-
hoc Bonferroni correction. For the 3D superimposion
ROIs, the mean and standard deviations ware calculated.
The level of significance of all tests was set at P < 0.05. For
the Intraclass correlation, a Cronbach’s alpha test was used
with a kappa of 0.81 to 1.00 indicating an Balmost perfect
agreement.^ Linear regression tests were performed
Clin Oral Invest
between T0–T1 and between T0 and T1–T0 on the lip
projection angles, SNA, SNB, ANB, Wits, and overjet.




Twenty-one patients were recruited to the treatment group.
Increased mobility of and local inflammations around the
plates occurred to one patient 3 months after the protraction.
These bone plates had to be removed and consequently, this
patient was excluded. The CBCT of two patients at T0 were
not in occlusion, which would provide inaccurate information
on the mandibular position and the vertical dimension. These
two subjects were therefore excluded. The mean age of the 18
included subjects (12 males, 6 females) was 11.3 ± 0.6 years,
slightly elder than the control subjects (p < 0.05). The sample
size and mean age of the three control groups were UG-nonC,
N = 10, 10.2 ± 1.1 years; UG-C1, N = 11, 10.2 ± 0.7 years (all
subjects with complete unilateral cleft lip and palate) and UG-
C2, N = 11, 9.8 ± 0.9 years (included mainly subjects with
complete unilateral cleft lip and palate and subjects with iso-
lated cleft palate). The observation periods (T1–T0) showed
no difference between the groups, being about 1.5 years
(Table 1).
Intraclass correlation coefficient in measurements
All intraclass correlation tests on the measurements presented
in this study showed an Balmost perfect agreement^ with an
ICC of 0.912 for cephalometric measurements and an ICC of
0.902 for lip projection measurements.
Facial profile and lip projection changes
Variations of individual treatment response were observed in
both sex groups. Two thirds of the subjects showed improve-
ment of the lip projection, half with great improvement
(Fig. 2a, between 10 and 26°), and half with mild to moderate
improvement (Fig. 2b, between 1 and 9°). One third of the
subjects showed unchanged or worsened lip projection
(Fig. 2c, between 0 and − 10°). Lip projection at T0 and
T1 showed a positive correlation (R2 = 45%, slope
p < 0.01, Fig. 3a). The changes between T0 and T1 (T1–
T0) seemed to show a weak but negative correlation with
the begin severity (T0) (R2 = 26%, slope p < 0.05, Fig. 3b).
Skeletal changes on 3D CBCT surface models
Table 2 presents the descriptive statistics for the skeletal and
dental changes from T0–T1 for the 18 consecutively treated
patients. As the voxel size of our CBCTwas set at 0.3 mm, all
measurements within the range of ± 0.3 mm were considered
within the measurement errors. The overall skeletal changes
took place mainly at the zygomatic-maxillary complex
(Fig. 4). The zygoma regions showed a total mean displace-
ment of 1.5 mm each side, consisting of 1.1 mm forward and
0.7 mm outward movement. No differences were detected
between left and right zygoma regions. The A, B, and Pg
regions showed a total mean displacement of 1.5 mm,
0.8 mm, and 0.7 mm respectively, all contributed mainly by
forward movement (Fig. 5). Similarly, the upper incisors
showed a total mean displacement of 1.9 mm.
Fig. 1 An illustration of the analysis of the horizontal and vertical components of A-ROI (a) and B-ROI (b) measurements of the total displacement
using the Frankfurt Horizontal plane as reference. Light blue: T0 model, yellow: T1model. Area analyzed is highlighted with a red dashed circle
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Overall changes at the sagittal plane on CBCT surface
models and cephalograms
Table 3 illustrated the differences in cephalometric measure-
ments between T0–T1 in the treatment and control groups.
Analysis at T0 showed significant difference between ANB
and Wits’value between UG-C2 and all the other groups (TG-
C/UG-non-C and UG-C1 <UG-C2, p < 0.05), which confirmed
the distinctive sagittal characteristics between the groups.
Significant improvement in overjet was only observed in
the treatment group (p < 0.05). Compared with the controls,
the treatment group showed significant increase in SNA and
ANB angles, a more forward movement of point A (+
2.0 mm) and more overjet improvement (2.3 ± 3.1 mm)
(p < 0.05 with all three controls), and increased Wits (+
1.33 mm). No unfavorable change at the vertical dimension
were observed, nor in the incisor inclinations. Mandibular
growth at the sagittal and vertical dimensions appeared com-
parable with all untreated groups (p > 0.05).
None of the parameters indicating treatment effect at the
sagittal dimension (SNA, SNB, ANB, Wits, and overjet)
showed a correlation between T1–T0 and T0. When the total
mean displacement of Nasion, A, B, and Pg was analyzed in
its horizontal and vertical components, the only significant
change was at the A point, indicating a 2-mm forward move-
ment (p < 0.05 from all three controls).
Since the bone anchor group had a relatively large sample
size than the control groups, it could possibly lead to false
positive results. As there was minor difference at T0 between
the cleft and non-cleft control groups with Class III malocclu-
sion (UG-non-C and UG-C1), an additional analysis was per-
formed by combining these two control groups resulting in a
sample size of 21. The results showed no change in the level
of significance in comparison with the analyses on two sepa-
rate control groups.
Figure 6 summarizes the mean displacement at the sagittal
plane during the observation period of the N, A, B, and Pg
points together with their horizontal and vertical components.
Here, it shows clearly that the total mean displacement of
these anatomical points was fairly comparable between the
four groups. The variations were manifested only in its hori-
zontal (A point) or vertical (B point) components.
Discussion
Evidence is lacking in the literature regarding the effective-
ness of different treatment options for growing subjects with
cleft lip and palate and Class III malocclusion. Inappropriate
camouflage dental compensation compromises the treatment
outcome skeletally and esthetically, and may moreover result































































































































































































































































































































































for an orthognathic surgery. To our knowledge, this is the first
study evaluating the treatment efficacy of bone-borne maxil-
lary protraction in growing cleft patients with Class III mal-
occlusion, in comparison with both untreated cleft and non-
cleft controls.
In the present study, bone-anchored maxillary protraction
therapy showed favorable results in cleft children with Class
III malocclusion. Improvement was observed in lip projection
and facial convexity in two thirds of the subjects. Skeletal
changes were most significant at the zygomatic regions in a
forward and outward direction, and at the maxillary complex
in a forward direction. Sagittally, forward displacement of A
point and limited forward displacement of B point contributed
to the less concave profile and improvement of the Class III
malocclusion. No unfavorable change at the vertical dimen-
sion or in the incisor inclinations was observed. Mandibular
growth at the sagittal and vertical dimensions appeared com-
parable between the treatment and all control groups during
the observation period.
Facemask therapy has been considered an effective treat-
ment modality for Class III malocclusion before the age of 10
[2, 24]. However, long-term effect and stability of this treat-
ment remain debatable [1]. Mandell et al. reported reduced
need for orthognathic surgery in patients with an early FM
therapy [24]. Comparison of short-term results between
facemask therapy and BAMP is not reliable due to distinct
age differences of the subjects at the start of treatment. A
recent systematic review showed the age range of face mask
treatment was between 5.85 and 10.1 in the included studies
[1], while for BAMP treatment the age range was 10–12 [14].
Importantly, comparison of the long-term results of early FM
therapy and BAMP, when available, will be very interesting.
Fig. 2 Facial profile and lip
projection before and after
maxillary protraction. a
Improvement of lip projection
between 10 and 26°, b
improvement between 1° and 9°,
c improvement between 0 and −
10°
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Anumber of treatment protocols using amaxillary expansion
and protraction reported favorable short-term results in non-cleft
subjects of 9–12 years old in terms of A point advancement [7,
25–29]. Most of the studies were retrospective, with relatively
small sample size or without untreated controls. In addition,
different bone-borne and tooth-borne appliances for expansion
and protraction were used with various durations, making com-
parison between the studies difficult. Using Alt-RAMEC proto-
col, Liou and Tsai (2005) reported an average of 5.8mmApoint
advancement in 10 unilateral cleft lip and palate subjects of 9–
12 years old, which stayed stable after 2 years [9].More recently,
Meazzini et al. (2015) using the same protocol in 26 UCLP
subjects of 12 years old reported similar amount of A point
advancement and a long-term follow-up on half of these subjects
showed stable results [8]. Within the limitations of the above-
mentioned studies, maxillary expansion seemed to enhance
the effect of maxillary protraction when performed at a
young age. The clinical merit of this combination therapy
needs to be explored further in the future.
Conventionally, position changes of ROIs in 3D surface
models or of cephalometric landmarks were presented in their
total displacement in the space. This may mask the true treat-
ment effect, as a displacement of 3 mm contributed mainly by
a horizontal or a vertical movement provides totally different
clinically interpretations. In the current study, all four groups
showed a total mean displacement of A point of about
2.5 mm. Only by separating its horizontal and vertical com-
ponents was it revealed that the favorable changes at the sag-
ittal plane in the treatment group, indicated by SNA, ANB,
Wits, and overjet measurements, were mainly the result of the
more forward movement of A point.
Inclusion of untreated control groups is of utter importance
when assessing the clinical effect of a new treatment modality
or when an existing therapy is applied on a different patient
category. A control group should be relevant in terms of the
key clinical symptoms and their underlying etiology in order
to serve the purpose for a proper reference. Inappropriate con-
trols may yield over- or underestimation of the efficacy of an
investigated therapy, and subsequently may result in ill-
definition of its treatment indications. Comparison of treat-
ment response of cleft subjects with non-cleft subject with
similar Class III phonotypes needs to be done with caution
as the underlying etiology of cleft-related Class III was mainly
related to intrinsic deficiency in maxillary growth and the
restrictive effect of scar tissues resulting from previous surger-
ies, while growth of the mandible was mostly normal [18, 30].
Differently, non-cleft Class III malocclusion could be a result
of either maxillary deficiency or mandibular redundancy or
both [31]. Moreover, different growth trends in cleft subjects
have been observed in longitudinal growth studies or follow-
up data of unoperated patients [32–34]. The present study
included three untreated groups with both cleft and non-cleft
Fig. 3 Correlation of lip
projection between T0–T1 and
between T0–(T1–T0). T1–T0
calculates the difference before
and after treatment by subtracting
T0 from T1. Positive values
indicate a favorable outcome
(more convex facial profile) and




subjects, in order to minimize the potential bias from one
single control group.
Though the sample size of the control groups is argu-
ably small, each group showed interestingly a distinctive
growth pattern during the observation period. The only
other study in literature including an untreated control
group (N = 18) showed that non-cleft subjects treated with
bone-anchored maxillary protraction (N = 21) had nearly
4 mm more sagittal movement of the maxilla and nearly
3 mm less forward growth of the mandible. No vertical
skeletal changes except an increase of the mandibular in-
cisors inclination were observed [14]. Yatabe et al. 2016,
2017 [15, 35], compared a Brazilian cleft group with Class
III malocclusions with de Clerck’s non-cleft subjects using
bone-anchored protraction [14]. Their study, with a similar
sample size but slightly elder study subjects and a larger
age range (9–13 years), reported no difference in maxil-
lary displacement between cleft and non-cleft subject but
overall larger displacement compared with our results.
Direct comparison between the two studies serves little
purpose, not only because the patient population was dif-
ferent in ethnic origin and the severity of Class III anom-
aly, but also in the superimposition methods. Yatabe et al.
2017 [15] superimposed surface models on anterior cranial
base only, and our study on both anterior cranial base and
foramen magnum. Previous studies comparing these two
methods [36] showed a significantly higher accuracy in
the latter method, though the accuracy of the former meth-
od was also of clinical relevance. Arguably, superimposi-
tion only on anterior cranial base may allow more vertical
variations than that on both anterior cranial base and fora-
men magnum. Therefore, it is not surprising the maxillary
displacement in its horizontal component between our study
and the cleft group of Yatabe et al. 2017 [15] (N = 24) is
comparable (zygoma 1.2 mm vs. 1.6 mm; A point 1.5 mm
Table 2 Mean values, standard deviations, and ranges of maxillary
protraction changes (mm) at each anatomic region of interest (ROI)
relative to the anterior cranial base superimposition
(N = 18) Mean SD Range
A Overall 1.5 1.3 − 0.1/4.8
Horizontal 1.5 1.2 − 0.1/3.8
Vertical − 0.1 0.5 − 1.9/0.7
B Overall 0.8 1.7 − 1.2/6.4
Horizontal 0.8 1.6 − 1.0/6.1
Vertical 0.2 0.3 − 0.7/0.7
Zygoma left Overall 1.7 0.9 0.1/3.3
Horizontal 1.2 0.7 0.2/2.3
Vertical 0.3 0.3 − 0.1/ 0.9
Transversal 0.9 0.6 0.0/2.3
Zygoma right Overall 1.4 1.0 − 0.2/3.7
Horizontal 1.1 1.0 − 0.8/3.3
Vertical 0.3 0.5 − 0.9/1.2
Transversal 0.6 0.6 − 0.1/1.6
Zygoma Overall 1.5 0.9 − 0.2/3.7
Horizontal 1.1 0.8 − 0.8/3.3
Vertical 0.3 0.4 − 0.9/1.2
Transversal 0.7 0.6 − 0.1/2.3
Nasion Overall 0.7 0.8 − 1.3/2.2
Horizontal 0.6 0.8 − 1.3/2.1
Vertical 0.0 0.3 − 0.5/0.8
Pogonium Overall 0.7 1.9 − 2.9/4.7
Horizontal 0.7 1.8 − 2.3/4.7
Vertical 0.2 0.3 − 0.1/1.0
U1 Overall 1.9 1.6 − 0.1/5.5
Horizontal 1.7 1.5 0.1/5.2
Vertical 0.2 0.6 − 0.6/1.3
The values are the mean for the total analyzed CBCTmodels measured in
mm. Forward, downward, and outward vectors are denoted positive; up-
ward, backward, and inward vectors are denoted negative
Fig. 4 Skeletal changes on 3DCBCTsurface models. a, bAn illustration
of color mapping of the 3D surface models from CBCT. Green indicates
no or minimal difference between T0 and T1 models. Values given as
positive or negative at the scale bar indicate outward or inward changes.
A front view (a) and a ¾ view (b)
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vs. 1.7 mm), both are less than those from the non-cleft group
(zygoma 1.8 mm, A point 2.4 mm); vertically, they reported a
larger displacement and even slight mandibular backward ro-
tation at B and Gonion in another study on largely the same
cleft group (N = 18, Yatabe et al. 2016) [35].
Using the same CBCT tomographic color mapping method
with the anterior cranial base as the superimposition reference,
Nguyen et al. [11], reported a mean forward displacement of
3.7 mm of the maxilla, and a forward displacement of 3.7 and
4.3 mm at the zygoma and the maxillary incisors, respectively,
on a group of non-cleft subjects (N = 25). It is unclear whether
overlap exists in the study objects between Nguyen et al. [11]
and the non-cleft group from Yatabe et al. 2017 [35].
Nevertheless, the displacements reported by Nguyen et al.
2011 [11] are more than twice what we have observed at the
corresponding sites. This seems to suggest though the treatment
outcomes point to the same favorable direction, bone-anchored
maxillary protraction in cleft subjects showed generally smaller
effect than in non-cleft patients.More independent clinical stud-
ies are needed in order to make the comparison meaningful in
the treatment efficacy between cleft and non-cleft subjects.
Vertically, cleft patients often showed hyperdivergency
[17]. Here, we did not observed any difference at the vertical
dimension between the treatment and the control groups at T0
or T1. Gonial angle was previously reported to be about 2.6°
smaller after bone-anchored maxillary protraction [14]. In our
subjects, gonial angle, though not statistically significant,
showed a mean decrease of 1.3°. Whether these changes are
related to the anterior or posterior rotation of the B point, both
were observed in our subjects, needs further investigation.
Transverse palatine suture has been demonstrated as the
largest separation of all sutures [37], possibly due to the anterior
directed force. Here, we showed on a CBCT model, of one of
the study subjects, significant opening of the transversal palatal
suture (Fig. 7). Experimentally, the transverse palatine,
zygomaticotemporal, and pterygopalatine sutures exhibited
the greatest response to extra oral forces with active osteogen-
esis and dramatically stretched fibers [38, 39]. Although suture
opening could not be typically found in every single patient
treated with the same protocol, our observation demonstrated
the potential of suture opening at the transversal palatal region
at a later age than previous recommended in the literature [5].
Regarding the treatment effect in relation to the severity of
Class III malocclusion at T0, the only correlation identified
was in the lip projection. Subjects with more severe/negative
lip projection, likely benefited more favorable improvement
Fig. 5 Skeletal changes on 3D CBCT surface models. a, b
Superimposition of T0 and T1 3D surface models to illustrate the
changes taking place at the zygoma arches, maxillary complex, and the
mandible. T0 (green) and T1 (mesh) models are registered and aligned on
the anterior cranial base and on occipital posterior of the foramen
magnum structures using the best-fit matching method, in a front view
(a), a sagittal view (b), an axial view from the top showing the zygomatic

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































during the observation period, though they still remained in a
relative more severe Class III malocclusion category.
Treatment effect at the sagittal dimension cannot be predicted
from any of the cephalometric parameters at T0, implying
indicators other than cephalometric parameters may yet be
identified.
Fig. 6 An illustration of the
overall changes in cephalometric
measurements. Cephalometric
data derived from CBCT from the
treatment group (a) and
cephalometric data from the three
control groups of UG-nonC (b),
UG-C1 (c), and UG-C2 (d). In
this schematic representation, the
mean displacement after
treatment of the N, Zyg, A, and B
points of our sample are shown
together with their horizontal and
vertical vectors. Red letters and
arrows indicate overall changes in
mm and in direction, hor
horizontal movement, vert
vertical movement, yellow
symbol on the upper lip indicates
a cleft group
Fig. 7 A CBCT illustration of opening (indicated by arrows) of the
transversal palatal suture in an axial view showing the palate (a) and a
sagittal view (b). Source: Interdisciplinary Therapy: Using Contemporary
Approaches for Complicated Cases, Kapila SD and Goonewardene M,
eds. Ann Arbor: Monograph 52, Craniofacial Growth Series, Department
of Orthodontics and Pediatric Dentistry and Center for Human Growth
and Development, the University of Michigan, 2017, pp. 99–112
Clin Oral Invest
A number of limitations in the present study need to be
acknowledged. The non-cleft Class III control group came
from a historical growth study, while the two cleft control
groups were from clinical archives which may bear potential
imbalance in distribution of patient characteristics and selec-
tion bias [40]. In both treatment and control cleft groups, some
subjects had undergone a short period of orthodontic treatment
of mild dental alignment with removable or partial fixed ap-
pliances because of severely malpositioned teeth. This might
have resulted in more dental effect in some subjects than in the
others. This was not ideal but it was unethical to postpone the
treatment when it was needed in preparation for secondary
bone graft or was requested by the patients for esthetical rea-
sons. Further, the sample size of the control groups is relative-
ly small mainly due to the very low prevalence of Class III
malocclusion and cleft lip and palate in the Netherlands.
Ethical reasons eliminated the possibility to obtain growth
data from deliberately untreated subjects. Though the small
sample size together with the large variations in individual
response have made it difficult for the therapeutic effect to
reach a statistical significance in some parameters, the clinical
relevance of the results should not be neglected on the grounds
of their statistical insignificance. The overall results manifest a
clear pattern towards improvement of skeletal Class III rela-
tionship. Future studies should aim at identifying the predict-
able factors for favorable responses in order to set better indi-
cations and/or more individualized protocols for optimal out-
come with this treatment modality.
As no previous publications or clinical guidelines were
available on treatment with anchored maxillary protrac-
tion in cleft children at the onset of the present study,
we arbitrarily included only subjects with mild and mod-
erate Class III malocclusion. Note worthily, even subjects
responded poorly or unfavorable at the A or B regions,
resulting in unchanged or worsening of the lip projection,
showed improvement at the midface confirmed by the
consistent finding of forward and outward displacement
of the zygomatic arches, with a total mean of 1.5 mm
per side contributing significantly to the improvement in
facial profile. This finding indicates a unique advantage of
bone-anchored maxillary protraction therapy that a Le
Fort I jaw surgery cannot offer, as by definition Le Fort
limits its operational area to below the zygomatic arches
and nasal floor. It might therefore be argued to include
patients with more severe Class III malocclusion for this
treatment modality, not with the goal to entirely correct
the skeletal dysplasia or avoid a jaw surgery, but to pro-
vide a better midface support to facilitate or complement
the treatment outcome of a later jaw surgery that is likely
already indicted. Undoubtedly, longer follow-up studies
are needed to demonstrate first the long-term treatment
effect and stability before this treatment modality can be
recommended or applied in more severe cases.
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